Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia
Clinical trial NCT00060294 · TERMINATED
Trial details
- NCT number
- NCT00060294
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2004-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.